Silgan Holdings SLGN Dispensing and Specialty Closures — Total adjusted EBIT
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Silgan Holdings in its filing.
Tagged under the XBRL concept slgn:EarningsBeforeInterestAndTaxesAdjusted.
The official record: Silgan Holdings’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Silgan Holdings's dispensing and specialty closures — total adjusted ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Silgan Holdings's dispensing and specialty closures — total adjusted EBIT?
- Silgan Holdings (SLGN) reported dispensing and specialty closures — total adjusted EBIT of $96.07M in Q1 2026.
- How has Silgan Holdings's dispensing and specialty closures — total adjusted EBIT changed year-over-year?
- Silgan Holdings's dispensing and specialty closures — total adjusted EBIT decreased by 3.2% year-over-year, from $99.2M to $96.07M.
- What is the long-term trend for Silgan Holdings's dispensing and specialty closures — total adjusted EBIT?
- Over 4 years (2021 to 2025), Silgan Holdings's dispensing and specialty closures — total adjusted EBIT has grown at a 9.2% compound annual growth rate (CAGR), from $295.19M to $419.94M.
- What does dispensing and specialty closures — total adjusted EBIT mean?
- Measures the segment's operating profitability by excluding non-recurring items, restructuring charges, and other adjustments. This metric allows for a normalized view of the segment's core operational performance, facilitating comparisons across different periods. It is a key indicator of the underlying health and cash-generating capability of the business unit.